MENU

SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases... Show more

Industry: #Biotechnology
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SLDB is expected to report earnings to fall 20.60% to -41 cents per share on November 11

Solid Biosciences SLDB Stock Earnings Reports
Q3'26
Est.
$-0.41
Q1'26
Beat
by $0.13
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.22
The last earnings report on May 12 showed earnings per share of -51 cents, beating the estimate of -64 cents. With 659.16K shares outstanding, the current market capitalization sits at 932.32M.
A.I. Advisor
published General Information

General Information

a developer of novel gene therapy platform for advancing disease

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
121
Web
https://www.solidbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BSMIX21.630.15
+0.70%
iShares Russell Small/Mid-Cap Idx Instl
PNECX12.67N/A
N/A
Virtus NFJ Dividend Value C
HAGCX46.89N/A
N/A
Carillon Eagle Mid Cap Growth C
ICBAX22.37N/A
N/A
ICON Natural Resources and Infras Inv
JLGPX80.56N/A
N/A
JPMorgan Large Cap Growth R3

SLDB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-4.08%
EDIT - SLDB
54%
Loosely correlated
+1.89%
FDMT - SLDB
51%
Loosely correlated
-2.37%
IMTX - SLDB
49%
Loosely correlated
+0.46%
RCKT - SLDB
49%
Loosely correlated
-3.74%
CRBU - SLDB
49%
Loosely correlated
-7.30%
More
Solid Biosciences (SLDB) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com